Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark

Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark

Item
http://www.wikidata.org/entity/Q37166491
Standard and reduced doses of dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study.Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available EvidenceTrends in the prescription of novel oral anticoagulants in UK primary care.Initiation of anticoagulation in atrial fibrillation: which factors are associated with choice of anticoagulant?Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients.Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry.Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study.Underuse of Anticoagulation in Older Patients with Atrial Fibrillation and CHADS2 Score ≥ 2: Are We Doing Better Since the Marketing of Direct Oral Anticoagulants?Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study.Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015.Changing paradigms in oral anticoagulation during cardioversion in Europe.Making it back to base: how recruitment to cohort studies affects outcomes.Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation.Signals of bleeding among direct-acting oral anticoagulant users compared to those among warfarin users: analyses of the post-marketing FDA Adverse Event Reporting System (FAERS) database, 2010-2015.Impact of the Health Insurance Coverage Policy on Oral Anticoagulant Prescription among Patients with Atrial Fibrillation in Korea from 2014 to 2016.
P2860

Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark

Item
http://www.wikidata.org/entity/Q37166491
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-vitamin K antagonist oral ...... al trends 2011-2015 in Denmark
@en
Non-vitamin K antagonist oral ...... l trends 2011-2015 in Denmark.
@nl
type
label
Non-vitamin K antagonist oral ...... al trends 2011-2015 in Denmark
@en
Non-vitamin K antagonist oral ...... l trends 2011-2015 in Denmark.
@nl
prefLabel
Non-vitamin K antagonist oral ...... al trends 2011-2015 in Denmark
@en
Non-vitamin K antagonist oral ...... l trends 2011-2015 in Denmark.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Non-vitamin K antagonist oral ...... al trends 2011-2015 in Denmark
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P698
P921
P932